Kaiser Health News, January 25, 2018. A Kaiser Health News analysis shows that hundreds of people have glided through the “revolving door” that connects the drug industry to Capitol Hill and to the Department of Health and Human Services. Experts say the cozy relationships don’t necessarily mean congressional staffers do favors for lobbyists they know, but the access doesn’t hurt.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
The Problem with Medical Device Approval
MedShadow, January 16, 2018. To get FDA approval for a medical device, a company needs to say that its device is “substantially equivalent” to an existing one. Devices might be easily approved without further safety and effectiveness studies.
Read More »Essure Device Stirring Trouble on the Hill
MedPage Today, November 14, 2017. After much controversy, Essure permanent contraceptive is supposed to be studied by Bayer and compared to “tubes tied.” Is the study delayed?
Read More »FDA Clears Electronic Earpiece to Block Opioid Withdrawal Symptoms
STAT News, November 15, 2017. An electronic earpiece has been cleared by the FDA as a device to block opioid withdrawal symptoms. There is limited evidence for how effective it is, and we won’t know what will happen to patients for whom it doesn’t work.
Read More »EpiPen Failures Cited in Seven Deaths This Year, FDA Files Show
Bloomberg News, November 2 2017: FDA reports reveal that EpiPen failures have been associated with seven deaths and 35 hospitalizations, highlighting serious concerns about the device’s reliability. The National Center for Health Research emphasized the urgent need for thorough investigations and improved safety measures to ensure the effectiveness of this critical allergy treatment.
Read More »